Latest news with #Keenali
Fibre2Fashion
23-06-2025
- Business
- Fibre2Fashion
FMC achieves key approval for rice herbicide in South Korea
FMC Corporation has achieved a significant milestone in bringing breakthrough herbicide technology to rice growers, securing regulatory approval for Dodhylex active ingredient in South Korea. The approval of the active ingredient is a critical step in FMC's commercialization process, paving the way for the introduction of formulated products. Pending regulatory decisions, FMC anticipates receiving registration for products powered by Dodhylex active in South Korea in 2026. This will provide South Korean rice growers with access to the first new mode-of-action herbicide developed in over three decades. Classified as the first and only Group 28 herbicide by both the Herbicide Resistance Action Committee (HRAC) and the Weed Science Society of America (WSSA), Dodhylex active offers a novel approach to managing yield-reducing and resistant grass weeds in rice production. The technology can selectively control grass weeds within a grass crop—a significant technical achievement that provides season-long control, regardless of cultivation method, addressing a critical challenge as herbicide resistance continues to threaten rice productivity across the region. The registration in South Korea represents the first full approval of this revolutionary herbicide technology in the world's largest rice-producing region. This registration builds on FMC's global momentum, following the registration in Peru and the conditional approval in the Philippines for Keenali herbicide, powered by Dodhylex active. The company has submitted regulatory applications across multiple countries in Asia and other regions, including Brazil, Colombia, Ecuador, India, Indonesia, Japan, Malaysia, Taiwan, Thailand, the United States and Vietnam, with additional submissions planned. FMC Corporation has secured regulatory approval in South Korea for Dodhylex active, a groundbreaking Group 28 herbicide and the first new mode-of-action for rice in over 30 years. The approval marks a major step toward product launch by 2026, offering season-long control of resistant grass weeds. This builds on earlier approvals in Peru and the Philippines, with global registrations underway. Note: The headline, insights, and image of this press release may have been refined by the Fibre2Fashion staff; the rest of the content remains unchanged. Fibre2Fashion News Desk (RM)
Yahoo
06-05-2025
- Business
- Yahoo
FMC (NYSE:FMC) Reports Sales Decline In Challenging First Quarter
FMC recently reported a challenging first quarter with a sales decline and a net loss, alongside the affirmation of a regular quarterly dividend. The election of Steven Merkt to the Board and the appointment of Sara Velazquez Ponessa were key organizational changes. The regulatory approval for the Keenali herbicide in Peru highlights product innovation efforts. Despite these developments, FMC's 1.33% price move aligns broadly with market trends, experiencing a similar movement amidst market fluctuations driven by tariff talks and a decline in key indices like the S&P 500 and Dow Jones. These factors collectively present a stable outlook. FMC has 4 warning signs (and 1 which is potentially serious) we think you should know about. NYSE:FMC Earnings Per Share Growth as at May 2025 The end of cancer? These 23 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's. In light of recent developments at FMC, the organizational changes, including the board election and regulatory approvals, may bolster investor confidence but have yet to significantly impact revenue or earnings forecasts. Despite these strategic shifts, FMC's total shareholder return over the past year stands at 38.41%, underscoring the volatility faced by the company amidst a complex operating environment. In contrast to the broader market and the US Chemicals industry, which saw returns of 8.2% and a decline of 8.9% respectively over the same one-year period, FMC's challenges in managing inventory and currency risks have contributed to this decline. Analysts continue to hold a consensus price target of US$47.56, which is 12.24% above the current share price of US$41.74, suggesting potential upside if the company can align its cost optimization and market expansion efforts with analysts' expectations. While the company's ongoing initiatives aim to capitalize on new market opportunities, any delays in these implementations could affect projected revenue growth of 5% per year. Similarly, profit margins, expected to rise from 9.5% to 11.2% in three years, remain contingent upon effective cost management and competitive positioning. The near-term share price performance, coupled with the discrepancy between current valuation and analyst price targets, accentuates the importance of FMC's ability to execute its strategy amidst current challenges. Our valuation report here indicates FMC may be undervalued. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
